Abstract
We investigate mucosalivary dispersal and deposition on horizontal surfaces corresponding to human exhalations with physical experiments under still-air conditions. Synthetic fluorescence tagged sprays with size and speed distributions comparable to human sneezes are observed with high-speed imaging. We show that while some larger droplets follow parabolic trajectories, smaller droplets stay aloft for several seconds and settle slowly with speeds consistent with a buoyant cloud dynamics model. The net deposition distribution is observed to become correspondingly broader as the source height H is increased, ranging from sitting at a table to standing upright. We find that the deposited mucosaliva decays exponentially in front of the source, after peaking at distance x = 0.71 m when H = 0.5 m, and x = 0.56 m when H = 1.5 m, with standard deviations ≈0.5 m. Greater than 99% of the mucosaliva is deposited within x = 2 m, with faster landing times further from the source. We then demonstrate that a standard nose and mouth mask reduces the mucosaliva dispersed by a factor of at least a hundred compared to the peaks recorded when unmasked.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by U.S. National Science Foundation COVID-19 RAPID Grant No. DMR-2030307.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
None required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* brchang{at}clarku.edu
Data Availability
All data is contained in the manuscript.
